Health Care, HIPAA, and Telemedicine Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Jan
9
2024
FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious Keller and Heckman LLP
Jan
9
2024
Protecting Healthcare Workers Against Violence [Podcast] Jackson Lewis P.C.
Jan
9
2024
Starting this Month, California Health Care Entities Will Need to Provide State Notice of Mergers Set to Close on or After April 1, 2024 Squire Patton Boggs (US) LLP
Jan
9
2024
New Illinois Protections Against Patient Medical Debt May Also Help Reduce Hospital Bad Debt McDermott Will & Emery
Jan
9
2024
Day 1 Notes from the 42nd Annual J.P. Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Jan
9
2024
CORE Releases 2022 Annual Outbreak Report Keller and Heckman LLP
Jan
9
2024
AI as an Aid – Emerging Uses in Healthcare: A Discussion with Jim Gatto Sheppard, Mullin, Richter & Hampton LLP
Jan
9
2024
Organ Procurement and Transplantation Network: What’s Next in Oversight and Reform McDermott Will & Emery
Jan
9
2024
California Publishes New Wage Theft Notice Reflecting Requirement to Notify Employees of Disaster Declarations Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
8
2024
Gold Dome Report – Legislative Day 1 (2024) Nelson Mullins
Jan
8
2024
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT Mintz
Jan
8
2024
California: Health Care Transactions “Material Change” Regulations are Finalized Foley & Lardner LLP
Jan
5
2024
Trending in Telehealth: December 21, 2023 – January 3, 2024 McDermott Will & Emery
Jan
5
2024
OIG Issues a Favorable Advisory Opinion on Vendor’s Offer of Gift Cards to Physician Practices for Recommending the Vendor’s Services Mintz
Jan
5
2024
New ONC Final Rule Expands Information Blocking Regulatory Exceptions McDermott Will & Emery
Jan
5
2024
EPA Releases Peer Review Comments on White Paper for Asbestos Part 2 Risk Evaluation Bergeson & Campbell, P.C.
Jan
5
2024
McDermottPlus Check-Up: January 5, 2024 McDermott Will & Emery
Jan
5
2024
CJEU Rules on Processing of Sensitive Data and Compensation Under the GDPR Hunton Andrews Kurth
Jan
5
2024
AI, Phishing Attacks, Healthcare, and a $480,000 OCR Settlement under HIPAA Jackson Lewis P.C.
Jan
5
2024
Ultragenyx to Pay $6 Million To Settle False Claims Act Case ArentFox Schiff LLP
Jan
5
2024
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy Epstein Becker & Green, P.C.
Jan
4
2024
California Health Care Transactions: Finalized Regulations Addressing Notice and Review Requirements from the Office of Health Care Affordability Polsinelli PC
Jan
4
2024
US EPA’s Draft Revisions to Technical Guidance for Assessing Environmental Justice in Regulatory Analysis Squire Patton Boggs (US) LLP
Jan
4
2024
The MHPAEA Proposed Rule: Scalability and the Plight of the Small(er) Self-Funded Plan McDermott Will & Emery
Jan
4
2024
California Mandates New Leave for Reproductive Loss Hunton Andrews Kurth
Jan
3
2024
NIOSH Reviews Past Nanotechnology Guidance and Needs for Future Research Bergeson & Campbell, P.C.
Jan
3
2024
Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement Proskauer Rose LLP
Jan
3
2024
Unpacking Averages: The Seasonality of FDA 510(k) Decision-Making and the Impact of Michigan Playing for a National Championship Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins